诺和锐联合甘精胰岛素与胰岛素泵对老年糖尿病患者疗效比较被引量：1

下载PDF

导出

摘要目的对比两种胰岛素强化治疗对老年糖尿病患者的效果。方法选取54例年龄大于60岁的糖尿病患者,随机分为两组,分别予以诺和锐联合甘精胰岛素(A组)和胰岛素泵(B组)治疗并对比分析。结果 B组血糖达标时间优于A组,差异有统计学意义(P<0.05)。治疗前及治疗后两组各点血糖均无统计学意义(P>0.05),治疗后两组患者血糖水平明显下降,各点与同组治疗前比较均有统计学意义(P<0.01),B组血糖达标时间优于A组,差异有统计学意义(P<0.05)。结论积极的胰岛素强化,可以有效稳定血糖,改善自身胰岛细胞功能。其中诺和锐用于胰岛素泵治疗老年糖尿病与诺和锐联合甘精胰岛素相比较,所需时间更短且安全性更佳。

作者何亮军徐竞

机构地区马鞍山人民医院内分泌科

出处《安徽医学》 2011年第9期1292-1294,共3页 Anhui Medical Journal

关键词老年糖尿病胰岛素强化治疗胰岛素泵

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献7

1徐武夷,姚合斌,刘月琴.老年糖尿病药物治疗进展[J].人民军医,2010,53(12):955-957. 被引量：14
2Retnakaran R,Yakubovich N,Qi Y,et al.The response to short-term intensive insulin therapy in type 2 diabetes.Diabetes Obes Metab,2010,12(1):65-71.
3张红杰,纪立农.口服葡萄糖耐量试验与馒头餐试验对2型糖尿病病人血糖代谢及酮症发生的影响[J].中国糖尿病杂志,2003,11(4):275-277. 被引量：15
4Abbatecola AM,Paolisso G.Diabetes care targets in older persons.Diabetes Res Clin Pract,2009,86(1):35-40.
5UKPDS Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.Lancet,1998,52 (9131):837-853.
6Greco D,Angileri G.Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.Diabetes Nutr Metab,2004,17(1):23-26.
7Prato S,Marchetti P,Bonadonna RC.Phasic insulin release and metabolic regulation in type 2 diabetes.Diabetes,2002,51 (Suppl 1):109-116.

二级参考文献11

1[3]American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 2002(suppl1):S50-S60.
2Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes:Realistic estimates for the year 2000 [J]. Diabetes Care, 2005, 28(9):2130- 2135.
3Abbatecola AM, Paolisso G. Diabetes care targets in older persons [J]. Diabetes Res Clin Pract, 2009, 86 (Suppl) :35-40.
4Dankner R, Geulayov G, Olmer L,et al. Undetected type 2 diabetes in older adults [J]. Age Ageing, 2009, 38(1):56-62.
5Hamnvik OPR, McMahon GT. Balancing risk and benefit with oral hypoglycemic drugs [J]. Mount Sinai J Med, 2009, 76 (3): 234-243.
6Abbatecola AM, Paolisso G, Corsonello A, et al. Antidiabetic oral treatment in older people: Does frailty matter? [J]. Drugs Aging, 2009, 26:53-62.
7Cayea D, Boyd C, Durso SC, Individualising therapy for older adults with diabetes mellitus[J]. Drugs Aging, 2007, 24(10) :851-863.
8The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes [J]. New Engl J Med,2008, 358(24) :2545-2559.
9Parks M, Rosebraugh C. Weighing risks and benefits of liraglutide: The FDA's review of a new antidiabetie therpay. [J].New Engl J Med, 2010,360(3) :774-777.
10胰岛β细胞功能研究协作组.正常人馒头餐试验过程中血糖、胰岛素、C肽的观察[J].中华医学杂志,1982,62(11):643-643.